Developing custom syringes for highly viscous formulations to be discussed at Pre-filled Syringes

SMi Reports: 'Developing custom syringes for highly viscous formulations' one of the many topics to be presented at the inaugural Pre-filled Syringes San Francisco Conference on September 14 and 15.
By: SMi Group
 
 
400x300
400x300
 
Spread the Word
Listed Under

Tag:
* Smipfsusa

Industry:
* Health

Location:
* Kensington - London, Greater - England

Subject:
* Features

KENSINGTON, U.K. - July 1, 2020 - PRLog -- SMi Group is holding the inaugural Pre-filled Syringes San Francisco conference, taking place on the 14th and 15th September 2020, in San Francisco, USA.

Who should attend:
• Drug-delivery developers
• Medical Device Engineers
• Primary Packaging material designers
• Secondary packagers
• Smart device developers
• Training device developers
• Device-safety solution providers
• Drug developers

To find out  more about The Inaugural Pre-Filled Syringes San Francisco conference please visit: http://www.prefilled-sanfrancisco.com/prlog7

The Pre-filled Syringes San Francisco Conference will be presenting a variety of topics, below are some key presentations:

'Developing custom syringes for highly viscous formulations'
• Gilead and West are developing a custom cyclic olefin polymer (COP) syringe to enable delivery of viscous formulations through subcutaneous injection needles
• Due to the high injection forces required, syringe stresses and failure modes had to be well understood to inform design improvements
• The final syringe design can withstand forces in excess of 500N, while remaining ISO 11040-6 compliant to facilitate fill/finish activities
Walter Goodwin, Device Engineer, Device Development & Clinical Packaging Engineering, Gilead Sciences

'Connected devices and their potential to deliver user benefits'
• What are connected systems of devices and why would a sponsor elect to develop a connected system
• Potential benefits of connected devices and the trade-offs
• Usability considerations of connected devices
Katie Atkinson, Manager, Human Factors Engineering, Bigfoot Biomedical

'Post-Market safety reporting (PMSR) for combination products – Implementation'
• Summary of implemented updates to the guidance for industry
• Strategies in implementation of PMSR and its application to drugs and devices
• Industry response and developments - what have we seen in industry already and what is still needed?
• Case study: implementation of PMSR for a combination product
Khaudeja Bano, Senior Medical Director, Abbott Laboratorie

To register and see brochure with the full workshop agenda, and speaker line-up visit: http://www.prefilled-sanfrancisco.com/prlog7

Pre-filled Syringes San Francisco
14TH – 15TH September 2020
Hyatt Centric Fisherman's Wharf, San Francisco

Proudly sponsored by: Credence MedSystems | Mitsubishi Gas Chemical | PHC Corporation | Plastic Ingenuity | Steris | Steri-Tek | Sumitomo | Zeon Speciality Materials|

For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088.

--END—

Contact
Jinna Sidhu
***@smi-online.co.uk
End
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Tags:Smipfsusa
Industry:Health
Location:Kensington - London, Greater - England
Subject:Features
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share